143 related articles for article (PubMed ID: 17159250)
1. Microvessel density in human normal and neoplastic parathyroids.
Viacava P; Bocci G; Fanelli G; Cetani F; Marcocci C; Bevilacqua G; Naccarato AG
Endocr Pathol; 2006; 17(2):175-81. PubMed ID: 17159250
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2, p53 and MIB-1 expression in normal and neoplastic parathyroid tissues.
Naccarato AG; Marcocci C; Miccoli P; Bonadio AG; Cianferotti L; Vignali E; Cipollini G; Viacava P
J Endocrinol Invest; 1998 Mar; 21(3):136-41. PubMed ID: 9591207
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis and lymphangiogenesis in parathyroid proliferative lesions.
Garcia de la Torre N; Buley I; Wass JA; Jackson DG; Turner HE
J Clin Endocrinol Metab; 2004 Jun; 89(6):2890-6. PubMed ID: 15181073
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein.
Erickson LA; Jin L; Wollan P; Thompson GB; van Heerden JA; Lloyd RV
Am J Surg Pathol; 1999 Mar; 23(3):288-95. PubMed ID: 10078919
[TBL] [Abstract][Full Text] [Related]
5. Tumour-associated fibroblasts contribute to neoangiogenesis in human parathyroid neoplasia.
Verdelli C; Avagliano L; Creo P; Guarnieri V; Scillitani A; Vicentini L; Steffano GB; Beretta E; Soldati L; Costa E; Spada A; Bulfamante GP; Corbetta S
Endocr Relat Cancer; 2015 Feb; 22(1):87-98. PubMed ID: 25515730
[TBL] [Abstract][Full Text] [Related]
6. Cox-2 expression in the oxyphilic cells of the normal, hyperplastic, and adenomatous parathyroid gland.
Bell CD; Vidal S; Kovacs K; Anderson J; Rotondo F
Endocr Pathol; 2004; 15(1):29-38. PubMed ID: 15067174
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone content distinguishes true normal parathyroids from parathyroids of patients with primary hyperparathyroidism.
Weber CJ; Russell J; Chryssochoos JT; Hagler M; McGarity WC
World J Surg; 1996 Oct; 20(8):1010-4; discussion 1014-5. PubMed ID: 8798358
[TBL] [Abstract][Full Text] [Related]
8. Chromogranin A and B in parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study.
Schmid KW; Hittmair A; Ladurner D; Sandbichler P; Gasser R; Tötsch M
Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):295-9. PubMed ID: 2024450
[TBL] [Abstract][Full Text] [Related]
9. Molecular Characteristics of Large Parathyroid Adenomas.
Agarwal A; Pradhan R; Kumari N; Krishnani N; Shukla P; Gupta SK; Chand G; Mishra A; Agarwal G; Verma AK; Mishra SK
World J Surg; 2016 Mar; 40(3):607-14. PubMed ID: 26669787
[TBL] [Abstract][Full Text] [Related]
10. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study.
Vasef MA; Brynes RK; Sturm M; Bromley C; Robinson RA
Mod Pathol; 1999 Apr; 12(4):412-6. PubMed ID: 10229506
[TBL] [Abstract][Full Text] [Related]
11. Expression of nm23 antimetastatic gene product in parathyroid hyperplasia, adenoma and carcinoma. An immunohistological assessment.
Al-Maghrabi JA; Asa SL
Saudi Med J; 2005 May; 26(5):728-31. PubMed ID: 15951858
[TBL] [Abstract][Full Text] [Related]
12. Relationships of parathyroid hormone, parathyroid secretory protein, parathyroid hormone messenger RNA, parathyroid secretory protein mRNA, and replication in human parathyroid adenoma and secondary hyperplasia tissues and cultures.
Weber CJ; Russell J; Costanzo MK; Karp F; Benjamin M; Hardy MA; Feind CR
Surgery; 1992 Dec; 112(6):1089-94; discussion 1094-5. PubMed ID: 1455310
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of GATA-3 in cytological identification of parathyroid tissues.
Takada N; Hirokawa M; Suzuki A; Higuchi M; Kuma S; Miyauchi A
Endocr J; 2016 Jul; 63(7):621-6. PubMed ID: 27097544
[TBL] [Abstract][Full Text] [Related]
14. Expression of nitric oxide synthases in parathyroid gland adenoma and parathyroid gland hyperplasia.
Kucera T; Veselý D; Pácová H; Martínek J; Astl J
Neuro Endocrinol Lett; 2005 Aug; 26(4):373-6. PubMed ID: 16136006
[TBL] [Abstract][Full Text] [Related]
15. Expression of parathyroid-specific genes in vascular endothelial progenitors of normal and tumoral parathyroid glands.
Corbetta S; Belicchi M; Pisati F; Meregalli M; Eller-Vainicher C; Vicentini L; Beck-Peccoz P; Spada A; Torrente Y
Am J Pathol; 2009 Sep; 175(3):1200-7. PubMed ID: 19644013
[TBL] [Abstract][Full Text] [Related]
16. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas.
Niveiro M; Aranda FI; Peiró G; Alenda C; Picó A
Hum Pathol; 2005 Oct; 36(10):1090-5. PubMed ID: 16226108
[TBL] [Abstract][Full Text] [Related]
18. Adrenomedullin immunoreactivity tissue distribution in parathyroids of the patients with primary hyperparathyroidism.
Letizia C; Ricci F; De Toma G; Cianci R; Alo P; Celi M; Panzironi G; Mingazzini PL; D'Erasmo E; Mazzuoli GF
Horm Metab Res; 2004 Jul; 36(7):480-4. PubMed ID: 15305232
[TBL] [Abstract][Full Text] [Related]
19. [Study on the cellular proliferation and endocrine activity of the parathyroid gland in hyperparathyroidism].
Hosokawa S
Nihon Hinyokika Gakkai Zasshi; 1993 Aug; 84(8):1424-31. PubMed ID: 8411803
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53, Ki-67 and Bcl-2 in parathyroid adenoma and residual normal tissue.
Hadar T; Shvero J; Yaniv E; Ram E; Shvili I; Koren R
Pathol Oncol Res; 2005; 11(1):45-9. PubMed ID: 15800682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
